Advertisement

ASCO 2022: New Data on IDH2-Mutant Alleles and Endasidenib in AML
Posted: 06/20/2022 | By: Chase Doyle

Question 1 of 5

What percentage of patients with IDH2 gene mutations have R140Q point mutations?

Choose 1

A
About 25%
B
About 50%
C
About 75%
D
About 100%

CategoriesView All Quizzes

Tumor Type


Additional Topics



Conference Coverage